- Home
- MAIA vs PMVP Comparison
MAIA vs PMVP Comparison
Compare MAIA & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- PMVP
- Stock Information
- Founded
- MAIA 2018
- PMVP 2013
- Country
- MAIA United States
- PMVP United States
- Employees
- MAIA N/A
- PMVP N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- MAIA Health Care
- PMVP Health Care
- Exchange
- MAIA Nasdaq
- PMVP Nasdaq
- Market Cap
- MAIA 46.7M
- PMVP 55.1M
- IPO Year
- MAIA 2022
- PMVP 2020
- Fundamental
- Price
- MAIA $1.88
- PMVP $1.25
- Analyst Decision
- MAIA
- PMVP Strong Buy
- Analyst Count
- MAIA 0
- PMVP 1
- Target Price
- MAIA N/A
- PMVP $5.00
- AVG Volume (30 Days)
- MAIA 529.1K
- PMVP 230.0K
- Earning Date
- MAIA 08-08-2025
- PMVP 08-07-2025
- Dividend Yield
- MAIA N/A
- PMVP N/A
- EPS Growth
- MAIA N/A
- PMVP N/A
- EPS
- MAIA N/A
- PMVP N/A
- Revenue
- MAIA N/A
- PMVP N/A
- Revenue This Year
- MAIA N/A
- PMVP N/A
- Revenue Next Year
- MAIA N/A
- PMVP N/A
- P/E Ratio
- MAIA N/A
- PMVP N/A
- Revenue Growth
- MAIA N/A
- PMVP N/A
- 52 Week Low
- MAIA $1.40
- PMVP $0.81
- 52 Week High
- MAIA $4.24
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- MAIA 56.41
- PMVP 64.21
- Support Level
- MAIA $1.80
- PMVP $0.96
- Resistance Level
- MAIA $2.15
- PMVP $1.36
- Average True Range (ATR)
- MAIA 0.13
- PMVP 0.09
- MACD
- MAIA 0.02
- PMVP 0.01
- Stochastic Oscillator
- MAIA 60.00
- PMVP 72.22
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.